JE Cleantech Holdings Limited (NASDAQ:JCSE) Sees Large Increase in Short Interest

JE Cleantech Holdings Limited (NASDAQ:JCSE) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 13,377 shares, an increase of 73.6% from the July 15th total of 7,706 shares. Based on an average daily trading volume, of 8,074 shares, the short-interest ratio is currently 1.7 days. Approximately 0.7% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of JE Cleantech from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

JE Cleantech Price Performance

JE Cleantech stock traded up $0.02 during midday trading on Monday, reaching $1.54. The company’s stock had a trading volume of 11,492 shares, compared to its average volume of 658,207. JE Cleantech has a fifty-two week low of $0.77 and a fifty-two week high of $2.50. The stock’s 50 day simple moving average is $1.38 and its 200 day simple moving average is $1.23. The company has a debt-to-equity ratio of 0.16, a current ratio of 2.72 and a quick ratio of 1.81.

About JE Cleantech

JE Cleantech Holdings Ltd. is an Israel-based environmental technology firm specializing in advanced water and wastewater treatment solutions. The company designs, manufactures and markets a suite of modular treatment systems that integrate proprietary membrane filtration, advanced oxidation processes, biological treatment and customized chemical formulations. Its offerings address water purification, recycling and process water challenges across municipal, industrial and agricultural end markets.

Through a combination of standardized equipment platforms and bespoke engineering services, JE Cleantech helps clients meet stringent regulatory requirements, reduce freshwater intake and lower overall treatment costs.